1. Home
  2. RMM vs PRQR Comparison

RMM vs PRQR Comparison

Compare RMM & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMM
  • PRQR
  • Stock Information
  • Founded
  • RMM 2019
  • PRQR 2012
  • Country
  • RMM United States
  • PRQR Netherlands
  • Employees
  • RMM N/A
  • PRQR N/A
  • Industry
  • RMM Trusts Except Educational Religious and Charitable
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMM Finance
  • PRQR Health Care
  • Exchange
  • RMM Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • RMM 314.6M
  • PRQR 309.5M
  • IPO Year
  • RMM N/A
  • PRQR 2014
  • Fundamental
  • Price
  • RMM $14.61
  • PRQR $2.71
  • Analyst Decision
  • RMM
  • PRQR Strong Buy
  • Analyst Count
  • RMM 0
  • PRQR 5
  • Target Price
  • RMM N/A
  • PRQR $7.60
  • AVG Volume (30 Days)
  • RMM 66.5K
  • PRQR 605.4K
  • Earning Date
  • RMM 01-01-0001
  • PRQR 11-07-2024
  • Dividend Yield
  • RMM 7.33%
  • PRQR N/A
  • EPS Growth
  • RMM N/A
  • PRQR N/A
  • EPS
  • RMM 0.96
  • PRQR N/A
  • Revenue
  • RMM N/A
  • PRQR $20,506,357.00
  • Revenue This Year
  • RMM N/A
  • PRQR $235.11
  • Revenue Next Year
  • RMM N/A
  • PRQR N/A
  • P/E Ratio
  • RMM $15.55
  • PRQR N/A
  • Revenue Growth
  • RMM N/A
  • PRQR 306.68
  • 52 Week Low
  • RMM $12.32
  • PRQR $1.61
  • 52 Week High
  • RMM $16.10
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • RMM 24.39
  • PRQR 37.43
  • Support Level
  • RMM $14.43
  • PRQR $2.48
  • Resistance Level
  • RMM $14.64
  • PRQR $2.83
  • Average True Range (ATR)
  • RMM 0.21
  • PRQR 0.28
  • MACD
  • RMM -0.11
  • PRQR -0.06
  • Stochastic Oscillator
  • RMM 9.68
  • PRQR 26.01

About RMM RiverNorth Managed Duration Municipal Income Fund Inc.

RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Share on Social Networks: